OUTLOOK THERAPEUTICS INC
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | – | 100.0% | – | – | 100.0% | 100.0% | – | |
| 0.8% | 4.4% | 1,358.1% | 1,371.6% | 79.4% | 52.1% | 668.0% | 750.9% | 926.2% | 568.5% | 0.9% | 0.7% | 0.1% | 0.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 16.9% | 16.9% | – | 29.2% | – | – | 117.2% | 188.9% | – | |
| 99.2% | 95.6% | 98.6% | 98.6% | 20.6% | 47.9% | 99.3% | 99.2% | 99.1% | 99.4% | 99.1% | 99.3% | 99.9% | -0.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -16.9% | -16.9% | – | 70.8% | – | – | -17.2% | -88.9% | – | |
| 851.1% | 4,363.7% | 1,358.1% | 1,371.6% | 71.0% | 52.1% | 668.0% | 750.9% | 926.2% | 568.5% | 925.9% | 743.9% | 76.8% | 99.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7,361.1% | 5,678.2% | – | 474.0% | – | – | 3,531.5% | 36,122.2% | – | |
| 1,343.1% | 1,606.8% | 1,327.4% | 1,148.6% | 118.7% | 459.8% | 317.0% | 284.5% | 782.0% | 271.9% | 288.4% | 314.3% | 47.5% | 39.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6,086.1% | 7,022.3% | – | 643.0% | – | – | 7,458.1% | 83,900.0% | – | |
| 1,328.4% | 1,606.8% | 1,327.4% | 1,148.6% | 120.9% | 459.8% | 317.0% | 1,035.4% | 782.0% | 491.9% | 1,214.2% | 1,058.0% | 124.3% | 139.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 13,430.6% | 12,683.7% | – | 1,117.0% | – | – | 10,989.6% | 120,022.2% | – | |
| -2,094.2% | -5,870.2% | -2,585.6% | -2,420.0% | -89.7% | -412.0% | -885.0% | -935.4% | -1,608.3% | -960.4% | -1,201.9% | -966.7% | -216.8% | -139.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -13,447.5% | -12,700.6% | – | -1,046.2% | – | – | -11,006.8% | -120,111.1% | – | |
| 46.8% | 161.4% | 410.4% | 576.0% | 84.8% | 93.0% | 119.3% | 148.6% | 143.2% | 105.0% | 164.4% | 185.3% | 3.6% | 10.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 42,868,143.2% | – | – | 3.3% | – | – | 2,354.1% | – | – | |
| -2,140.9% | -6,298.7% | -2,654.2% | -1,758.6% | -202.7% | -657.0% | -976.8% | -1,092.4% | -1,644.9% | -912.2% | -1,597.9% | -893.7% | -217.5% | -283.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3,345.4% | 10,214.9% | – | -1,338.8% | – | – | -3,494.3% | -225,311.1% | – | |
| -20.8% | 1.3% | 376.0% | 540.4% | 17.1% | -408.2% | 119.3% | 84,547,280.1% | -64.4% | 14,092,509.4% | 37.0% | -133.1% | -45.0% | 7.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10,214,664,963.2% | – | – | – | – | – | 455.6% | – | |
| -2,140.9% | -6,300.1% | -2,654.2% | -1,758.6% | -219.6% | -248.9% | -976.8% | -1,092.4% | -1,580.5% | -912.2% | -1,597.9% | -760.6% | -172.5% | -283.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3,345.4% | 10,214.9% | – | -1,338.8% | – | – | -3,494.3% | -225,766.7% | – | |
| -1,972.1% | -5,916.7% | -2,019.5% | -961.3% | -94.8% | -476.4% | -762.8% | -837.2% | -1,395.0% | -730.1% | -1,306.1% | -565.7% | -198.7% | -270.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -13,430.6% | -12,683.7% | – | -1,333.5% | – | – | -10,983.0% | -225,311.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.